Factor VIII
According to CEO Eugene Chan, the CE designation is just the first of more to come, as the company enters the diagnostics market with a focus on hematological testing.
BloodCenter of Wisconsin Offers New Type of Test in US to Accurately Diagnose von Willebrand Disease
Premium
The new ELISA test measures the interaction of a patented gain-of-function GPIb construction with von Willebrand factor in a patient sample.